Latest Health News

Xstate Resources Limited has had its trading suspension lifted as it meets key ASX listing requirements, marking a new chapter for the mining company.

Thrive Tribe Technologies has raised approximately $500,000 through a discounted share placement, aiming to bolster its working capital. The move follows shareholder approval and involves a significant issuance of new shares.

Downer EDI Limited has announced its key shareholder dates for 2025, including the Annual General Meeting scheduled for November 11 and the final dividend payment on October 2. These dates mark important milestones for investors in one of Australia and New Zealand's leading infrastructure service providers.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

TMK Energy Limited’s securities have been suspended from ASX trading due to a missed periodic report deadline, raising questions about the company’s regulatory adherence and market outlook.

Solstice Minerals is set to commence a maiden 5,000m drilling program at its Nanadie Copper-Gold Project in Western Australia, aiming to significantly expand its current mineral resource. The initial phase targets lateral and depth extensions of a substantial copper-gold system with promising geological indicators.

OMG Group has significantly expanded its Oat Milk Goodness PrOATein ready-to-drink range to nearly 1,000 Woolworths stores nationwide, backed by a recent $2 million capital raise and plans for new product launches.

InteliCare Holdings has raised $2 million through a two-tranche placement to accelerate its AI-driven aged care platform and terminated a convertible note facility to streamline its capital base.

Coventry Group has launched a $20 million entitlement offer at a 15% discount to reduce debt and bolster working capital. Eligible shareholders can also apply for additional shares through a shortfall facility.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

Control Bionics Limited has confirmed its compliance with ASX continuous disclosure rules following an inquiry about the timing and content of its financial results announcements.

4DMedical confirms its partnership with AstraZeneca in Brazil and announces a new contract supporting Australia’s National Lung Cancer Screening Program, signaling strategic growth in respiratory imaging.